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Introduction
Anthrax toxin, one of the two major virulence factors produced 
by Bacillus anthracis, is composed of three independent poly-
peptide chains: the protective antigen (PA), which is involved in 
target cell binding; the edema factor (EF), a calmodulin- dependent 
adenylate cyclase; and the lethal factor (LF), a zinc-dependent 
metalloprotease (for reviews see Collier and Young, 2003; Abrami 
et al., 2005; Scobie and Young, 2005). Only PA is able to bind to 
target cells; thus, EF and LF must always act in binary combina-
tion with PA to be transported to the target cell cytosol, where they 
exert their activities. The two identifi  ed PA receptors, tumor endo-
thelial marker 8 (TEM8) and capillary morphogenesis gene 2 
(CMG2), are type I transmembrane proteins sharing  60% ho-
mology in their extracellular von Willebrand factor A domains and 
68% identity in the fi  rst 145 residues of their cytoplasmic tails 
(Scobie and Young, 2005).
A relatively clear view of the mode of action of anthrax 
toxin has emerged over recent years (for reviews see Collier and 
Young, 2003; Abrami et al., 2005; Scobie and Young, 2005). PA 
is produced as an 83-kD protein that is unable to interact with 
EF and LF. At the target cell surface, proteolytic processing of 
PA83 leads to PA63, which remains receptor bound and can 
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  polymerize into a heptameric (PA
7mer) ring called the prepore. 
This prepore is able to bind up to three molecules of EF and/or 
LF, thus leading to a large hetero-oligomeric complex contain-
ing EF–LF–PA
7mer and receptors (for reviews see Abrami et al., 
2005; Scobie and Young, 2005). Once formed, this complex is 
rapidly internalized via a pathway that depends both on lipid 
rafts and clathrin (Abrami et al., 2003). The complex is then de-
livered to early endosomes, where it associates with intralumi-
nal vesicles (Abrami et al., 2004). At the low pH of endosomes, 
the prepore undergoes a conformational change that leads to its 
membrane insertion and pore formation. Interestingly, the pH 
sensitivity is determined by the receptor, and a lower pH is re-
quired when PA
7mer is bound to CMG2 when compared with 
TEM8 (Rainey et al., 2005; Wolfe et al., 2005). Low pH also 
triggers partial unfolding of EF and LF, which can translocate 
across the PA
7mer channel (Krantz et al., 2005). Because channel 
formation appears to occur preferentially in the intraluminal 
vesicles of the multivesicular endosomes, EF and LF end up in 
the lumen of these vesicles (Abrami et al., 2004). Final release 
of EF and LF from endosomes to the cytoplasm requires back 
fusion events between intraluminal vesicles and the limiting 
membrane at the level of late endosomes (Abrami et al., 2004).
Because EF and LF are unable to bind to cells or cross 
membranes on their own, binding to PA is an absolute prerequi-
site for internalization and intoxication. Therefore, PA receptors 
must remain at the cell surface until heptamerization and bind-
ing of the enzymatic subunits have taken place. In fact, PA83 is 
poorly internalized in comparison with PA63 (for reviews see 
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T
he anthrax toxin is composed of three indepen-
dent polypeptide chains. Successful intoxication 
only occurs when heptamerization of the   receptor-
binding polypeptide, the protective antigen (PA), allows 
binding of the two enzymatic subunits before endocy-
tosis. We show that this tailored behavior is caused by 
two counteracting posttranslational modiﬁ  cations in the 
cytoplasmic tail of PA receptors. The receptor is palmi-
toylated, and this unexpectedly prevents its association
with lipid rafts and, thus, its premature ubiquitina-
tion. This second modiﬁ  cation, which is mediated by the 
E3 ubiquitin ligase Cbl, only occurs in rafts and is re-
quired for rapid endocytosis of the receptor. As a 
  consequence, cells expressing palmitoylation-defective 
mutant receptors are less sensitive to anthrax toxin be-
cause of a lower number of surface receptors as well as 
premature internalization of PA without a requirement 
for heptamerization.T
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Collier and Young, 2003; Abrami et al., 2005; Scobie and Young, 
2005) as a result of a differential localization on the plasma 
membrane (Abrami et al., 2003). Whereas PA83 localizes to the 
glycerophospholipidic region, PA63 (in particular the heptam-
eric form) is found in specialized cholesterol-rich domains 
called lipid rafts. This raft association is essential for subse-
quent internalization of the toxin (Abrami et al., 2003). There-
fore, although it is receptor mediated, anthrax toxin endocytosis 
is actually toxin driven.
To understand the molecular mechanisms that govern this 
well-orchestrated behavior of anthrax toxin receptors at the cell 
surface, we investigated the roles of posttranslational modifi  ca-
tions of the receptor cytoplasmic tails. We focused on two modi-
fi  cations: S-palmitoylation and ubiquitination. S-palmitoylation 
is a reversible lipid modifi  cation involving the addition of a sat-
urated 16-carbon palmitate moiety to specifi  c cysteines via a 
thioester linkage. This modifi  cation is used by several hydro-
philic proteins such as Ras to associate with membranes but is 
also found in transmembrane proteins such as the transferrin re-
ceptor (Alvarez et al., 1990), LAT (linker protein for activation of 
T cells; Zhang et al., 1998), infl  uenza HA (Scheiffele et al., 1997), 
or the G protein of the vesicular stomatitis virus (Mack and 
Kruppa, 1988). The exact function of this modifi  cation in mem-
brane proteins is mostly unclear, but it might modulate the inter-
action of these proteins with membranes or membrane domains 
(Smotrys and Linder, 2004) as well as with other proteins.
Ubiquitination is the addition of a ubiquitin (Ub) moiety 
to cytoplasmic lysines by E3 Ub ligases, the third enzymes in 
the ubiquitination pathway (Hicke and Dunn, 2003). This added 
Ub itself may or may not be subsequently ubiquitinated on Lys
48 
or on Lys
63 leading to polyubiquitin chains (Haglund and Dikic, 
2005). Although polyubiquitination on Lys
48 is essentially in-
volved in the degradation of proteins by the proteasome, monou-
biquitination (the addition of a single Ub moiety to one or 
multiple lysines) as well as polyubiquitination on Lys
63 have 
been shown to be involved in endocytosis of plasma membrane 
proteins (G-coupled receptors, growth factors, and transporters; 
Hicke and Dunn, 2003) and sorting of internalized receptors 
into multivesicular bodies (Katzmann et al., 2002).
We report that TEM8 and CMG2 are targets for both pal-
mitoylation and ubiquitination and that these two modifi  cations, 
via counteracting effects, control receptor endocytosis.
Results
Characterization of TEM8/1-HA 
and CMG2/4-V5
TEM8 and CMG2 both exist as four isoforms, two of which, in 
each case, act as anthrax toxin receptors: isoforms 1 and 2 of 
TEM8 (TEM8/1 and TEM8/2) and isoforms 1 and 4 of CMG2 
(CMG2/1 and CMG2/4; for review see Scobie and Young, 
2005). These isoforms differ only in their cytoplasmic tails 
(Fig. 1 A); TEM8/2 has a far shorter cytoplasmic tail than 
TEM8/1 and CMG2/1, and CMG2/4 differs only in the last 
12–13 residues. Even between TEM8 and CMG2, the long 
tails have a very high degree of conservation (Fig. 1 A). There-
fore, we have focused this study mainly on TEM8/1 but 
  repeated key experiments with the short TEM8/2 isoform as 
well as with CMG2/4.
TEM8/1 was tagged with an HA epitope at the COOH 
terminus and was either transiently transfected or stably ex-
pressed in receptor-defi  cient CHO cells (CHO
∆ATR; Liu and 
Leppla, 2003). Expression levels were overall higher upon tran-
sient transfection (Fig. 1 B) but were still readily detectable in 
the stably TEM8/1-HA–expressing cells (Fig. 1, B and C). Most 
of the expressed receptor was present at the cell surface as indi-
cated by its sensitivity to cell surface trypsinization (Fig. 1 D). 
TEM8-HA always migrated as a doublet with an upper smeared 
band (Fig. 1 B, m) and a lower well-defi  ned band (Fig. 1 B, p), 
the intensity of which varied greatly from experiment to experi-
ment. We investigated whether this migration pattern was 
caused by glycosylation because the extracellular domain of 
TEM8 has three predicted N-glycosylation sites. Treatment of 
cells with tunicamycin, an inhibitor of N-glycosylation, led to 
the appearance of a third, lower mobility band (u; unglycosi-
lated) with a concomitant decrease in the intensity of bands 
m and p (Fig. 1 E). N-glycosidase F treatment of control cell ex-
tracts led to the complete disappearance of bands m and p to the 
benefi  t of band u (Fig. 1 E), showing that m and p both corre-
spond to glycosylated TEM8. Band m was endoglycosidase H 
(Endo H) resistant, and band p was Endo H sensitive (Fig. 1 E). 
This shows that TEM8 in band m (mature) had acquired com-
plex Golgi-modifi  ed sugars, whereas that in band p (precursor) 
contained incompletely modifi  ed sugars.
CMG2/4 was expressed with a COOH-terminal V5 tag 
(Dowling et al., 2003). As for TEM8, CMG2/4-V5 migrated as 
a smear plus a lower molecular weight band (Fig. 1 F). Both 
bands were sensitive to N-glycosidase F treatment, and, as for 
TEM8, only the lower band was sensitive to Endo H (Fig. 1 F). 
Altogether, this indicates that CMG2/4 is also glycosylated, 
as predicted by the presence of two N-glycosylation sites in 
the ectodomain.
PA DRM association is palmitoylation 
dependent
We have previously shown that the anthrax toxin modifi  es the 
surface distribution of its receptor, inducing its clustering in 
cholesterol-rich raftlike domains. We wondered whether post-
translational modifi  cations of the receptor tail could be in-
volved in regulating interactions of TEM8 and CMG2 with 
membrane domains.
TEM8/1 and /2 as well as CMG2/1 and /4 all contain cys-
teine residues in their cytoplasmic tails, which are potential 
sites for S-palmitoylation (Linder and Deschenes, 2004). More 
specifi  cally, all four proteins have two conserved juxtamembra-
nous cysteines (Fig. 1 A; Cys-346 and Cys-347 in TEM8), 
a third cysteine is conserved between TEM8/1 (Cys-481) and 
CMG2, and a fourth unconserved cysteine is found in TEM8/1 
(Cys-521) and CMG2/1 (Cys482).
To test whether palmitoylation plays a role in anthrax toxin 
endocytosis, we analyzed whether the palmitoylation inhibitor 
2-bromopalmitate (Webb et al., 2000) would affect the raft asso-
ciation of PA63 in BHK cells, a cell line that expresses transmem-
brane isoforms of both TEM8 and CMG2  (unpublished data).T
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We fi rst verifi  ed that PA binding was not affected by the treat-
ment (Fig. 2 A). Raft association was then monitored by follow-
ing the association with detergent-resistant membranes (DRMs; 
Brown and London, 1998). PA63 was associated with DRMs 
in control cells as previously observed (Abrami et al., 2003) but 
shifted to the detergent-soluble fractions in drug-treated cells 
(Fig. 2 B). This was not caused by a general disruption of lipid 
rafts because glycosyl-phosphatidylinositol–anchored pro-
teins, followed here using the glycosyl-  phosphatidylinositol–
 specifi   c bacterial toxin aerolysin (Fivaz et al., 2002) as well 
as caveolin-1, remained primarily in the DRM fractions. Al-
though caveolin-1 is palmitoylated on three cysteines, the 
modifi  cation is not required for DRM association (Dietzen 
et al., 1995). The inhibitory effect of 2-bromopalmitate on 
PA63-raft association was also accompanied by the inhibition of 
endocytosis as refl  ected by a lack of SDS-resistant PA
7mer pore 
and the absence of LF-mediated cleavage of one of the LF sub-
strates, the MAPK kinase MEK1 (Fig. 2 C; for review see Collier 
and Young, 2003).
To test whether 2-bromopalmitate inhibited the heptamer-
ization process itself, we designed an assay to detect cell sur-
face–formed prepores. These are SDS sensitive and, therefore, 
are not detected by SDS-PAGE. However, they can be converted 
to the SDS-resistant phenotype by submitting cell extracts to 
low pH (pH 4.5) before SDS-PAGE analysis, as illustrated in 
Fig. 2 C (middle left) for control cells. The prepore was unde-
tectable for 2-bromopalmitate–treated cells (Fig. 2 C).
TEM8 and CMG2 are palmitoylated
The aforementioned experiments show that palmitoylation 
events are important for anthrax toxin raft association and hep-
tamerization. To determine whether the receptors themselves 
are palmitoylated, TEM8/1-HA and CMG2/4-V5 were immuno-
precipitated from lysates of 
3H-palmitic acid–labeled CHO
∆ATR 
cells transiently transfected with the respective constructs. Ra-
diolabeled bands with motilities similar to that of TEM8/1-HA 
(Fig. 3 A) and CMG2/4-V5 (Fig. 3 B), respectively, were detected. 
This band was sensitive to in vitro hydroxylamine treatment 
Figure 1.  TEM8/1 and CMG2/4 are glycosylated. (A) Alignment of the cytoplasmic tails of human TEM8 and human CMG2 using the SIM software of the 
EXPASY server (www.expasy.ch). Regions of identity are shown in yellow, lysine residues in green, and cysteine residues in red. Numbering of the residues 
corresponds to that of TEM8/1. The asterisks label the lysine mutants in the K6R mutant described in Fig. 7. (B and C) CHO
∆ATR cells untransfected and 
stably or transiently transfected (for 48 h; B) with a TEM8/1-HA construct were analyzed by Western blotting (40 μg of protein/lane; B) or immunoﬂ  uores-
cence (C) using an anti-HA antibody. Bar, 10 μM. (D) CHO
∆ATR cells stably expressing TEM8/1-HA were submitted or unsubmitted to surface trypsinization 
at 4°C and subsequently analyzed for the presence of TEM8/1-HA by Western blotting. (E) CHO
∆ATR cells transiently expressing TEM8/1-HA were grown in 
the presence or absence of tunicamycin. Control cell extracts were subsequently left untreated or treated with N-glycosidase F or Endo H. The effects of these 
treatments were analyzed by SDS-PAGE followed by Western blotting against the HA tag. (B and E) Band u, unglycosilated form; p, glycosylated precursor; 
m, mature form. (F) Extracts of CHO
∆ATR cells transiently expressing or not expressing CMG2/4-V5 were left untreated or treated with N-glycosidase F or 
Endo H and subsequently analyzed by SDS-PAGE followed by Western blotting against the V5 tag.JCB • VOLUME 172 • NUMBER 2 • 2006  312
(Fig. 3 A) or cellular treatment with 2-bromopalmitate (Fig. 
3 C) as shown for TEM8/1-HA, indicating that palmitate addi-
tion occurred via a thioester bond. The short isoform of TEM8 
containing only two cysteines was also palmitoylated (Fig. S1, 
available at http://www.jcb.org/cgi/content/full/jcb.200507067/
DC1), as was CMG2/1 (not depicted).
To investigate when during the life cycle of TEM8/1 pal-
mitoylation occurred, 
3H-palmitate labeling was performed ei-
ther in the presence of cycloheximide to inhibit protein synthesis 
or in the presence of brefeldin A to inhibit transport from the 
endoplasmic reticulum to the Golgi. Neither drug signifi  cantly 
affected the amount of immunoprecipitated receptor (Fig. 3 C, 
anti-HA Western blot). However, both drugs led to an  50% 
reduction in 
3H-palmitate incorporation, as quantifi  ed by densi-
tometry, but not to full inhibition (Fig. 3, C and D), suggesting 
that palmitoylation occurs both in the early secretory pathway 
and later in the life cycle of the protein. A pulse-chase per-
formed after 
3H-palmitate incorporation showed that the palmi-
tate groups were lost within an hour (Fig. 3 E). This loss was 
caused by the reversible nature of the modifi  cation and not by 
degradation of the protein because a pulse-chase experiment 
 using  [
35S]cysteine/methionine showed that the half-life of 
TEM8/1-HA in these experiments well exceeded 5 h (Fig. 3 E; 
same 
35S curve as in Fig. 5 B).
TEM8/1 is palmitoylated on multiple 
cysteines
To investigate which of the four TEM8/1 cytoplasmic cysteines 
can be palmitoylated, we fi  rst concentrated on the two juxta-
membrane cysteines because TEM8/2, which contains only 
these two cysteines, is palmitoylated (Fig. S1). Moreover, palmi-
toylation sites adjacent to the transmembrane region have been 
Figure 2.  Palmitoylation events are required for DRM as-
sociation and internalization of PA. (A and B) Control BHK 
cells were pretreated or untreated with bromopalmitate 
and were incubated with 500 ng/ml nicked PA63 and 
20 ng/ml aerolysin for 1 h at 4°C followed by 10 min at 
37°C. (A) Cell extracts were submitted to SDS-PAGE fol-
lowed by Western blotting to reveal PA63, aerolysin, and 
caveolin-1 (Cav-1). (B) Cells were solubilized in 1% Triton 
X-100, run on an OptiPrep gradient, and each fraction 
was analyzed by SDS-PAGE followed by Western blot-
ting against PA, aerolysin, and caveolin-1. (C) BHK cells 
were pretreated with bromopalmitate and incubated with 
500 ng/ml nicked PA63 for 1 h at 4°C followed by dif-
ferent times at 37°C. Cell extracts (40 μg of protein) were 
analyzed by SDS-PAGE and Western blotting to reveal 
the SDS-resistant PA
7mer pore and MEK1 (NH2-terminal 
directed). To detect the prepore (SDS-sensitive nonmem-
brane-inserted PA
7mer), cell extracts were submitted to an 
acid pulse before SDS analysis.
Figure 3.  TEM8/1 and CMG2/4 anthrax toxin recep-
tors are palmitoylated. CHO
∆ATR cells transfected with 
TEM8/1-HA (A) or CMG2/4-V5 (B) were incubated with 
3H-palmitic acid for 2 h before immunoprecipitation using 
anti-tag antibodies. Immunoprecipitates were split into two, 
run on 4–20% gels, and analyzed either by autoradiogra-
phy (
3H-palmitate) or Western blotting (anti-tag HA or V5). 
(C) Before 
3H-palmitic acid incorporation, TEM8/1-HA–
  expressing cells were pretreated either with cycloheximide, 
2-bromopalmitate, or brefeldin A and were analyzed by 
autoradiography (
3H-palmitate) or Western blotting (anti-
tag HA). (D) Autoradiograms from C were quantiﬁ  ed by 
densitometry using ScanAnalysis software (Biosoft). Error 
bars correspond to SD (n = 3). (E) CHO
∆ATR cells tran-
siently transfected for 48 h with TEM8/1-HA cDNA were 
pulsed either for 2 h with 
3H-palmitic acid or for 30 min 
with [
35S]cysteine/methionine and were chased for dif-
ferent times. After anti-HA immunoprecipitation, samples 
were analyzed by SDS-PAGE followed by autoradiogra-
phy and densitometry (
3H) or Phosphoimager analysis 
(
35S; same curve as in Fig. 5 B). Results were normalized 
to the values at time = 0.MODIFICATIONS OF ANTHRAX TOXIN RECEPTORS • ABRAMI ET AL. 313
previously reported for several proteins such as CD4 (Bijlmakers 
and Marsh, 2003) or members of the SNARE family of mem-
brane fusion proteins (Rothman, 1994). Cysteines at positions 
346 and 347 in TEM8/1 were changed to alanine in single (mu-
tants AC and CA) and double (mutant AA) mutants. All three 
mutants were expressed to lower levels than wild type (WT; Fig. 
4 A). This was not a result of lower transfection effi  ciencies be-
cause equivalent TEM8/1 expression levels were observed when 
treating cells with the proteasome inhibitor MG132 (Fig. 4 B).
To compare cells that express similar amounts of re-
ceptor and have expression levels that allow the detection 
of 
3H-  palmitate, incorporation was performed on MG132-
Figure 4.  TEM8/1 is palmitoylated on multiple cysteines. (A–C) CHO
∆ATR 
cells were transiently transfected for 48 h with WT (CC) or mutant TEM8/1-HA 
cDNA in which one or both of the ﬁ  rst two cytoplasmic cysteines were 
changed to alanine (mutants AC, CA, and AA). Cells were treated (B) or 
untreated (A) with the proteasome inhibitor MG132. 40 μg of cell extracts 
were analyzed by SDS-PAGE and Western blotting against the HA tag. 
(C) CHO
∆ATR cells transfected with WT or mutant TEM8/1-HA were incu-
bated with MG132 and 
3H-palmitic acid for 2 h and submitted to immuno-
precipitation against the HA tag. Samples were analyzed by SDS-PAGE fol-
lowed by autoradiography and Western blotting against HA. (D–F) Similar
experiments were performed on single to quadruple mutants of the four
cysteine residues. (G) CHO
∆ATR cells transiently transfected for 48 h with WT 
(CCCC) or mutant TEM8/1-HA cDNAs were incubated with 500 ng/ml 
PA83 for 1 h at 4°C followed by 30 min at 37°C. 40 μg of cell extracts 
were analyzed by SDS-PAGE and Western blotting against PA.
treated cells. Only when the second cysteine was modifi  ed 
were lowerlevels of 
3H-palmitate incorporation observed (Fig.
4 C), indicating that Cys-347is palmitoylated in the WT protein. 
The observation thatthe double mutant still incorporated signi-
fi  cant amounts of 
3H-palmitate, however, indicated that other 
cysteines were modifi  ed. Thus, Cys-481 and Cys-521 in TEM8/1 
were also changed to alanine in single to quadruple mutants. 
Once more, all mutants were expressed at lower levels than the 
WT receptor(Fig. 4 D), an effect that could similarly be over-
come by treating cells with MG132 (Fig. 4 E). These mutants 
were expressed at the cell surface as indicated by their ability to 
bind PA (Fig. 4 G).
The quadruple mutant AAAA and the AAAC mutant did 
not incorporate 
3H-palmitate (Fig. 4 F). However, the fact that 
the CCCA mutant in repeated experiments had a somewhat 
lower incorporation than the WT TEM8/1 suggests that Cys-
521 can be palmitoylated, possibly in a subpopulation of recep-
tors, but only when other palmitoylation sites are present. The 
AAC
481A mutant was always signifi  cantly modifi  ed, as were all 
of the mutants with a cysteine at position 481. Thus, repeated 
palmitoylation experiments showed that mutations of Cys-347 
and Cys-481 always led to a drastic decrease in 
3H-palmitate 
incorporation, whereas the mutation of Cys-521 had a milder 
but signifi  cant effect. It has previously been observed that the 
mutation of palmitoylation sites leads to the aberrant palmi-
toylation of remaining cysteines, especially in double-cysteine 
motifs (Percherancier et al., 2001; Sims and Wiedmer, 2001; 
Wiedmer et al., 2003). Therefore, we focused further experi-
ments on the quadruple AAAA mutant in comparison with the 
WT (CCCC) receptor.
Palmitoylation modulates the half-life 
of TEM8
The lower expression levels of all palmitoylation mutants when 
compared with WT suggested that palmitoylation affects the 
half-life of the receptor. Therefore, pulse-chase experiments 
using [
35S]cysteine/methionine labeling were performed in 
transiently transfected CHO
∆ATR cells. The initial level of syn-
thesis was very similar for the WT and AAAA mutant receptors 
(Fig. 5 A). However, 50% of the AAAA mutant was lost after 
 130 min (Fig. 5 B), whereas >60% of the WT receptors were 
still present after 5 h. The 30% loss in AAAA TEM8/1 during 
the fi  rst hour of chase (Fig. 5, A and B) suggests that palmi-
toylation might somewhat affect folding/traffi  cking through the 
early secretory pathway. Because this cannot account for the 
drastic reduction in receptor half-life, we investigated whether 
defective palmitoylation could cause premature targeting of 
TEM8/1 to lysosomes.
We fi  rst generated stable cell lines expressing AAAA 
TEM8/1 and found, as expected, lower steady-state expression 
levels (Fig. 5 C). Cells were then fed with an inhibitor of lyso-
somal enzymes, leupeptin (inhibitor of serine and cysteine pro-
teases). This treatment led to some protection of the WT receptor 
(at the low exposure shown in Fig. 5 D, CCCC TEM8/1 was 
only detected in leupeptin-treated cells). However, the effect 
was far more pronounced for AAAA TEM8/1 (Fig. 5 D). Intra-
cellular accumulation was confi  rmed by immunofl  uorescence JCB • VOLUME 172 • NUMBER 2 • 2006  314
(Fig. 5  E). Although in the absence of treatment, AAAA 
TEM8/1-HA was undetectable by fl  uorescence microscopy, leu-
peptin feeding led to the appearance of punctate perinuclear struc-
tures (Fig. 5 E), which were presumably late endosomes/lysosomes. 
Figure 5. Palmitoylation-deﬁ  cient  TEM8/1 
has a reduced half-life. (A) CHO
∆ATR cells tran-
siently transfected for 30 h with plasmids ex-
pressing WT or AAAA TEM8/1 were submitted 
to a pulse-chase analysis with [
35S]methionine/
cysteine. Immunoprecipitated receptors were 
followed by autoradiography (8-d exposure). 
Mature TEM8 is labeled m, and the Endo 
H–sensitive precursor is labeled p. The band 
labeled with an asterisk is an unknown coim-
munoprecipitated protein that is not detected 
in other cells, such as HeLa. (B) TEM8/1 radio-
activity was quantiﬁ  ed using a Phosphoimager 
(Bio-Rad Laboratories). Results correspond to 
the mean of two experiments and were normal-
ized to the radioactivity at time = 0. (C–E) Cell 
extract for CHO
∆ATR cells stably expressing WT 
(CCCC) or mutant AAAA TEM8/1-HA were 
analyzed by Western blotting (C and D) or 
  immunoﬂ  uorescence (E) against HA. (D and E) 
Cells were left untreated, treated with MG132, 
or fed with leupeptin. In E, the exposure times 
were identical for all images, but a 75% cut-
off ﬁ  lter on the excitation beam was used for 
the MG132 condition. Untransfected CHO
∆ATR 
cells are shown for comparison. Bar, 10 μM.
Figure 6. Palmitoylation-deﬁ  cient TEM8/1 associates constitutively with 
DRMs. (A) DRMs were prepared from CHO
∆ATR cells stably expressing 
CCCC or AAAA TEM8/1-HA, and the distribution of receptors was ana-
lyzed by Western blotting against HA. A higher exposure is shown for 
the AAAA mutant. (B) CHO
∆ATR cells stably expressing AAAA TEM8/1-HA 
were left untreated or treated with 2-bromopalmitate. DRMs were pre-
pared, and the distribution of mutant TEM8/1-HA and caveolin-1 was 
analyzed by Western blotting. Mature TEM8/1-HA is labeled m, and the 
Endo H–sensitive precursor is labeled p.
This was in contrast with the effect of MG132, which also led to 
a massive increase in staining but primarily at the plasma mem-
brane (Fig. 5 E). Thus, palmitoylation of TEM8/1 appears to be 
crucial in preventing premature targeting to lysosomes.
Palmitoylation is a negative regulator of 
TEM8 DRM association
We next investigated whether the palmitoylation of TEM8/1 is 
involved in regulating its association with DRMs (Abrami et al., 
2003). Stably expressed WT TEM8/1 was found in detergent-
sensitive fractions (Fig. 6 A, left) as previously described 
(Abrami et al., 2003). In contrast, AAAA TEM8/1 was almost 
entirely associated with DRMs (Fig. 6 A, right). These observa-
tions indicate that palmitoylation acts as a negative regulator of 
TEM8/1 DRM association. The drastic difference between the 
AAAA mutant and the WT receptor suggests that the bulk of the 
WT receptor is palmitoylated at steady state. These observations 
also raise the interesting possibility, which is not addressed in 
this study, that depalmitoylation by a protein-thioesterase activ-
ity could be a mechanism for the regulation of raft association. 
Regulation of protein localization by palmitoylation/depalmi-
toylation has been proposed for soluble proteins in particular 
(Drenan et al., 2005; Rocks et al., 2005).
The observation that palmitoylation-defi  cient  TEM8/1 
(AAAA) is exclusively found in DRMs (Fig. 6 A) is in apparent 
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DRM association of PA63 (Fig. 2 B). Therefore, we tested 
whether the drug would also affect the DRM association of 
AAAA TEM8/1. The mature Endo H–resistant form of the mu-
tant receptor entirely relocalized to the detergent-soluble frac-
tions (Fig. 6 B), indicating the involvement of a palmitoylation 
event in the association of AAAA TEM8/1 with DRMs, the sub-
strate of which must be a protein other than the receptor itself.
PA induced ubiquitination of anthrax 
toxin receptors
We have previously shown that heptamerization of PA not only 
triggers the redistribution of the toxin–receptor complex to lipid 
rafts but also triggers its rapid endocytosis (Abrami et al., 2003). 
We investigated whether this toxin-induced uptake could be 
caused by a second posttranslational modifi  cation of the receptor 
cytoplasmic tail that would be raft dependent. We focused our 
attention on ubiquitination (Haglund and Dikic, 2005). CHO
∆ATR 
cells transiently transfected with TEM8/1-HA or CMG2/4-V5 
were treated with PA for various times. After immunoprecipita-
tion of the receptors, Western blots were performed with anti-tag 
and anti-Ub antibodies. The addition of the toxin clearly led to 
the appearance of a smeared Ub-positive band both for TEM8/1 
(Fig. 7 A) and for CMG2/4 (Fig. 7 B). The absence of ladder was 
suggestive of monoubiquitination rather than polyubiquitination 
with long chains, as observed for Ub
48 ubiquitination and protea-
somal degradation (Haglund and Dikic, 2005). Experiments per-
formed with the shorter TEM8/2 isoform similarly led to the 
detection of a ubiquitinated band (Fig. S2, available at http://
www.jcb.org/cgi/content/full/jcb.200507067/DC1). The ubiqui-
tinated band detected for TEM8/2 was smaller than that detected 
for TEM8/1, suggesting that the receptor itself was the modifi  ed 
protein rather than an interacting partner.
To confi  rm this, lysine mutagenesis was performed. Of 
the 16 lysines in TEM8/1 and 14 in CMG2/4, we fi  rst changed 
Lys-352 to arginine in TEM8 and the corresponding Lys-350 in 
CMG2/4 because (1) it is the only lysine common to TEM8/1 
and TEM8/2; (2) it is conserved between TEM8 and CMG2; 
and (3) Valdez-Taubas and Pelham (2005) suggested that the 
palmitoylation of Tlg1 prevents access of juxtamembranous ly-
sines by E3 ligases. Although the ubiquitinated band could still 
be detected after the addition of PA to K352R TEM8/1 expres-
sion cells, ubiquitination was greatly diminished (Fig. 7 C). 
A stronger effect was obtained when mutating 6 of the 16 lysines 
to arginine (K
6R mutant in which all lysines labeled with an as-
terisk in Fig. 1 A were changed to arginine, including Lys-352). 
These experiments confi  rm that TEM8/1 is the substrate of the 
ubiquitination reaction and that Lys-352 is one of the modifi  ed 
sites but that additional lysines might be modifi  ed. The effect 
of mutating the fi  rst conserved juxtamembranous lysine to argi-
nine was even more drastic in CMG2/4. No Ub-positive band 
could be   detected in PA-treated K350R CMG2/4–transfected 
cells (Fig. 7 D).
To investigate whether ubiquitination of the receptor is 
important for endocytosis of the anthrax toxin, we monitored 
the appearance of the SDS-resistant PA
7mer pore in lysine 
  mutant-expressing cells. As shown in Fig. 7 (C and D), the ap-
pearance of the SDS-resistant pore was either delayed or 
strongly diminished in the TEM8/1 and CMG2/4 lysine mutant–
expressing cells, demonstrating that ubiquitination of the re-
ceptor is important for effi  cient endocytosis.
TEM8 ubiquitination is DRM mediated
Because endocytosis of TEM8 requires both raft association 
(Abrami et al., 2003) and ubiquitination (Fig. 7), we investi-
gated whether these two events were linked. DRMs were iso-
lated from transiently transfected CHO
∆ATR cells. The bulk of 
TEM8/1 was found in detergent-soluble fractions (Fig. 8 A, 
left), as also observed in Fig. 6 A. In marked contrast, ubiqui-
nated TEM8/1 was detected exclusively in DRMs (Fig. 8 A, left). 
Figure 7.  PA triggers ubiquitination of its receptor. CHO
∆ATR cells were 
transiently transfected for 48 h with WT (A and B) or mutant forms (C and D) 
of TEM8/1-HA or CMG2/4-V5. 1 μg/ml PA83 was either added or not 
added to cells for 1 h at 4°C and shifted for different times to 37°C. After 
immunoprecipitation against HA (A and C) or V5 (B and D), samples were 
analyzed by Western blotting using anti-Ub, anti-HA, or V5 and anti-PA. In 
TEM8/1 K6R, lysines 352, 372, 373, 374, 412, and 414 were changed 
to arginine. HC, heavy chain.JCB • VOLUME 172 • NUMBER 2 • 2006  316
When cells were treated with the toxin before Triton X-100 sol-
ubilization, PA63 was associated with DRMs (as in Fig. 2 B) 
and led to the recruitment of toxin-bound TEM8/1 to this frac-
tion (Fig. 8 A, right). Concomitantly, the ubiquitinated form of 
TEM8/1 was increased in the same fraction (Fig. 8 A). Raft im-
pairment by cholesterol extraction using the sequestering agent 
β-methylcyclodextrin (ßMCD) led to a strong   inhibition of 
PA-induced TEM8/1 ubiquitination (Fig. 8 B). This observation 
suggests that microdomain association precedes and is required 
for this posttranslational modifi  cation.
The E3 Ub ligase Cbl is required 
for anthrax toxin endocytosis
Cbl is an E3 Ub ligase that can interact with lipid rafts (Lafont 
and Simons, 2001; Haglund et al., 2004). To test for the involve-
ment of Cbl in anthrax toxin endocytosis, we decided to per-
form RNA silencing. HeLa cells were used because of their 
human origin (the sequence of hamster Cbl is not available) and 
their high transfection effi  ciencies. These cells express TEM8 
as indicated by the pH sensitivity of PA channel formation 
(Rainey et al., 2005). As shown in Fig. 8 C, Cbl could be effi  -
ciently silenced by this method. The absence of Cbl did not af-
fect binding of the toxin as indicated by the unaltered presence 
of PA83/PA63. However, appearance of the PA
7mer pore was 
drastically inhibited (Fig. 8 C). To investigate the effect of Cbl 
RNA interference on the ubiquitination of TEM8 itself, RNA 
interference–treated cells were transfected with TEM8/1-HA, 
and toxin-induced ubiquitination after immunoprecipitation of 
the receptors was measured. As shown Fig. 8 D, the ubiqui-
tinated form of TEM8/1 could not longer be detected. Theses 
experiments show that Cbl is responsible for the ubiquitination 
of TEM8/1 and its subsequent internalization.
Constitutive ubiquitination of 
palmitoylation-deﬁ  cient TEM8/1 and the 
consequences as an anthrax toxin receptor
We found that AAAA TEM8/1 is constitutively associated with 
DRMs and that TEM8 ubiquitination is a raft-dependent modi-
fi   cation. Therefore, we wondered whether AAAA TEM8/1 
would be constitutively ubiquitinated. As shown in Fig. 9 A, the 
steady-state ubiquitination level of AAAA TEM8/1 was mark-
edly higher than that of WT CCCC TEM8/1 (especially when 
comparing the levels of Ub vs. HA) both in stable cell lines and 
upon transient transfection (note that after immunoprecipitation 
of TEM8/1-HA from transiently transfected cells, the levels of 
expressed receptors seem to be similar even though analysis of 
total extracts shows a lower abundance of the AAAA mutant). 
Ubiquitination of AAAA TEM8/1 was dependent on the integ-
rity of lipid rafts because the removal of cholesterol using 
ßMCD led to a drastic reduction in the level of AAAA TEM8/1 
ubiquitination. This later observation also indicates that in-
creased ubiquitination of AAAA TEM8/1 is not a consequence 
of misfolding of the cytoplasmic tail as a consequence of muta-
genesis, because such an event would have been insensitive to 
acute cholesterol extraction from the plasma membrane.
Constitutive ubiquitination of the AAAA TEM8/1 and, 
thus, its constitutive endocytosis are likely to affect its ability to 
act as an anthrax toxin receptor. To address this issue directly, 
we monitored the cleavage kinetics of the LF target MEK1. 
Whereas MEK1 underwent LF-dependent cleavage in WT 
TEM8/1–expressing cells, the MAPK kinase remained intact in 
the AAAA TEM8/1–expressing cells during the time course of 
the experiment (Fig. 9 C). To test whether this lack of cleavage 
was only a result of the reduced number of surface-expressed 
receptors (levels of TEM-HA), we treated AAAA TEM8/1–
 expressing cells with a higher concentration of PA to reach similar 
amounts of bound PA as on WT TEM8/1–expressing cells (Fig. 
S3, available at http://www.jcb.org/cgi/content/full/jcb.200507067/
DC1). Interestingly, even under these conditions, MEK1 cleav-
age in AAAA TEM8/1–expressing cells was minimal (Fig. S3), 
indicating that reduced PA binding does fully account for the 
reduced MEK1 cleavage in these cells.
Because AAAA TEM8/1 undergoes signifi  cant consti-
tutive endocytosis, we tested whether it would mediate the 
Figure 8.  Endocytosis of anthrax toxin receptor requires DRM-mediated 
ubiquitination and the E3 ligase Cbl. (A) CHO
∆ATR cells transfected for 48 h 
with WT TEM8/1-HA were incubated with 1 μg/ml PA83 for 1 h at 4°C fol-
lowed by 40 min at 37°C, solubilized in Triton X-100 at 4°C, and separated 
on an OptiPrep gradient. TEM8/1-HA was immunoprecipitated from each 
fraction and analyzed by SDS-PAGE and Western blotting using anti-Ub, 
anti-HA, and anti-PA antibodies. (B) CHO
∆ATR cells transfected for 48 h with 
WT TEM8/1-HA were treated with βMCD to extract cholesterol, incubated 
with 1 μg/ml PA83 for 1 h at 4°C, and shifted for different times at 37°C. 
After immunoprecipitation with anti-HA beads, samples were analyzed by 
Western blotting using anti-Ub and anti-HA antibodies. (C) HeLa cells were 
transfected or untransfected with siRNAs against Cbl for 72 h and incubated 
with 500 ng/ml PA83 for different times at 37°C. Cell extracts were blotted 
for Cbl, tubulin (as an equal loading marker), and PA. (D) HeLa cells were 
untransfected or transfected with siRNAs against Cbl for a total of 72 h in 
total. 24 h later, these cells were additionally transfected with TEM8/1-HA 
for 48 h and incubated with 500 ng/ml PA83 for different times at 37°C. 
TEM8/1-HA was immunoprecipitated from each fraction and analyzed by 
SDS-PAGE and Western blotting using anti-Ub and anti-HA antibodies.MODIFICATIONS OF ANTHRAX TOXIN RECEPTORS • ABRAMI ET AL. 317
  internalization of PA83, which is an event that does not occur 
with the WT receptor and for which PA heptamerization is re-
quired (Abrami et al., 2003; Liu and Leppla, 2003). In this 
study, we made use of a mutant PA (PA
SNKE; Abrami et al., 
2003) that is modifi  ed in the furin consensus cleavage site and, 
thus, remains in the PA83 form. As expected (Abrami et al., 
2003), PA
SNKE was not internalized by WT receptors and was 
sensitive to surface trypsinization (Fig. 9 D). In contrast, all 
cell-bound PA
SNKE became trypsin resistant in AAAA TEM8/1–
expressing cells, indicating that it had been completely endo-
cytosed (Fig. 9 C, right).
Discussion
TEM8 and CMG2 are ideal anthrax toxin receptors because of 
their low steady-state endocytosis rate and rapid uptake upon 
clustering (Abrami et al., 2003). These properties guarantee that 
PA is not internalized unless it has heptamerized and, thus, 
bound EF and/or LF. In this study, we have analyzed the mech-
anisms that govern the cell surface behavior of the receptors.
Receptor palmitoylation
Although the number of cytoplasmic cysteines varies from two 
to four in the various transmembrane TEM8 and CMG2 iso-
forms, this study indicates that these isoforms are all palmi-
toylated at least on the second juxtamembranous cysteine. In 
addition, long isoforms, such as those shown here for TEM8/1, 
can be palmitoylated on the more distal cysteines. These differ-
ent palmitoylation sites could be the substrate of more than one 
palmitoyl transferases, 23 of which have been identifi  ed in the 
human genome (Fukata et al., 2004; Linder and Deschenes, 
2004). The fi  rst palmitoylation event appears to occur in the 
early secretory pathway, as indicated by the  50% inhibition of 
palmitate incorporation induced by cycloheximide or brefeldin 
A treatment and also indirectly suggested by the increased deg-
radation of the palmitoylation-defi  cient mutant at early times 
after synthesis.
Based on the study of the palmitoylation-defi  cient AAAA 
TEM8/1 mutant, palmitoylation regulates the lifetime of TEM8/1 
by preventing premature internalization and targeting to lyso-
somes. Lysosomal targeting in the absence of proper palmi-
toylation has previously been observed for other transmembrane 
proteins such as CCR5 (Percherancier et al., 2001) or the yeast 
SNARE Tlg1 (Valdez-Taubas and Pelham, 2005). Increased turn-
over of membrane proteins in the absence of normal palmi-
toylation, however, is not systematic because the yeast SNAREs 
Suc1 and Syn8 are not prematurely targeted to degradation in 
 palmitoylation-defi  cient cells (Valdez-Taubas and Pelham, 2005).
However, the most surprising fi   nding concerning the 
 palmitoylation-defi  cient mutant was its high affi  nity for DRMs. 
This appears to be in contradiction with the accepted consensus 
in the lipid raft fi  eld that palmitoylation allows association with 
cholesterol-rich domains. Careful analysis of the data illustrates 
that the effect of palmitoylation on a transmembrane protein 
cannot be predicted because a variety of situations have been 
described. LAT is palmitoylated, and this modifi  cation is essen-
tial for DRM association (Zhang et al., 1998); caveolin-1 is tri-
ple palmitoylated, but this modifi  cation is not necessary for 
DRM association (Dietzen et al., 1995); and, fi  nally, the trans-
ferrin receptor (Alvarez et al., 1990) and the G protein of the 
vesicular stomatitis virus (Mack and Kruppa, 1988), which are 
two well-characterized nonraft proteins, are both palmitoylated. 
We now illustrate a fourth scenario in which palmitoylation ac-
tually prevents DRM association.
Interesti5ngly, the DRM association of TEM8 was still 
  sensitive to 2-bromopalmitate, indicating the requirement for 
other palmitoylated proteins. Based on this observation, we 
would like to propose that palmitoylation of TEM8 regulates its 
  interaction with a partner protein, the palmitoylation of which is 
Figure 9.  Cells expressing the palmitoylation-deﬁ  cient TEM8/1 are less 
sensitive to anthrax toxin. (A and B) Anti-HA immunoprecipitation ex-
periments were performed on CHO
∆ATR cells stably or transiently (48 h) 
expressing CCCC or AAAA mutant TEM8/1-HA. Western blotting was 
performed against Ub and HA. (B) Cells were left untreated or treated 
with βMCD before lysis and immunoprecipitation. (C) CHO
∆ATR cells sta-
bly expressing WT or AAAA TEM8/1-HA were treated with 500 ng/ml 
PA83 and 200 ng/ml LF at 37°C for different times. 40 μg of cell ex-
tracts were analyzed by SDS-PAGE followed by Western blotting against 
PA, HA, and MEK1 (NH2-terminal–directed antibody). (D) CHO
∆ATR cells 
transiently (48 h) expressing WT and AAAA mutant TEM8/1-HA were 
treated with 500 ng/ml of the furin-resistant PA
SNKE mutant for 1 h at 
4°C and shifted to 37°C for different times. Surface-bound toxin was 
shaved off with trypsin (10 min at 37°∆). To prevent lysosomal degrada-
tion of the internalized PA, cells were treated with 10 μM nocodazole 
to block microtubule-dependent transport to late endosomes. 40 μg of 
cell extracts were analyzed by SDS-PAGE and Western blotting against 
PA and HA.JCB • VOLUME 172 • NUMBER 2 • 2006  318
required for the toxin-induced raft association of WT TEM8. 
This interaction would be essential for the toxin’s action based 
on the inhibitory effect of 2-bromopalmitate on PA surface hep-
tamerization, which is a prerequisite for endocytosis via the WT 
receptor (Fig. 10).
Toxin-induced receptor ubiquitination
The cytoplasmic tails of all isoforms of TEM8 and CMG2 con-
tain lysine residues in numbers that vary from 3 in TEM8/2 to 
14 in CMG2/4 and 16 in TEM8/1, all of which are potential 
ubiquitination sites. We found that anthrax PA triggers the ubiq-
uitination of each of these receptors. Indeed, Lys-352 in TEM8/1 
and the corresponding Lys-350 in CMG2/4 acquire this modifi  -
cation, and, thus, mutation of these lysines leads to the inhibi-
tion of PA endocytosis. Ubiquitination TEM8 is mediated by 
the E3 Ub ligase Cbl as shown by RNA silencing on HeLa cells. 
The modifi  cation is raft dependent because it occurred prefer-
entially in DRMs and was inhibited by cholesterol extraction 
from the plasma membrane. Moreover, DRM association  appears 
to be suffi  cient to induce ubiquitination because the AAAA 
TEM8/1 palmitoylation-defi  cient mutant is constitutively DRM 
associated as well as ubiquitinated.
The fi  ndings described in this study—i.e., that both palmi-
toylation and ubiquitination of TEM8 are important for anthrax 
toxin action—appear to be in disagreement with previous work 
showing that anthrax PA could be endocytosed in cells expressing 
a variety of COOH-terminal TEM8 truncation mutants (Liu and 
Leppla, 2003). In this latter study, all transmembrane-  truncated 
TEM8 mutants, with the exception of the mutant lacking the 
  entire cytoplasmic tail, retained palmitoylation and ubiquitina-
tion sites because they were all longer than TEM8 isoform 2. 
The completely tailless mutant was still able to internalize PA 
(Liu and Leppla, 2003). However, the conditions used were very 
different (higher PA concentrations and longer in  cubation times) 
than those in this study, and kinetics were not measured.
Concluding remarks
We have identifi  ed two posttranslational modifi  cations of the 
anthrax toxin receptors, palmitoylation and ubiquitination, that 
have opposite effects on the uptake of receptors and play a cru-
cial role in the mode of toxin action. Palmitoylation serves to 
spatially segregate the receptors away from their Ub ligase, 
which, in turn, controls their endocytosis and turnover.
In terms of anthrax toxin’s mode of action, an intricate 
sequence of events can be envisioned (Fig. 10). PA binds to its 
receptors, and subsequent furin processing and heptameriza-
tion likely trigger a conformational change in the receptor, 
leading to its association with partner proteins and/or depalmi-
toylation. Altogether, this induces the redistribution of the 
toxin–receptor complex to lipid rafts, where an encounter with 
the E3 Ub ligase Cbl occurs. Ubiquitination of TEM8/CMG2 
allows an interaction with proteins of the endocytic machinery 
harboring Ub-interacting domains (Hicke and Dunn, 2003). 
One of these is likely to be Eps15, which is involved in the for-
mation of clathrin-coated pits, contains three Ub-interacting 
motifs (for review see Polo et al., 2003), and is required for an-
thrax toxin endocytosis (Abrami et al., 2003). Recruitment of 
the endocytosis machinery leads to rapid uptake and transport 
to early   endosomes, where anthrax toxin receptor ubiquitina-
tion might play a second role in sorting into multivesicular bod-
ies (Katzmann et al., 2002).
This study also illustrates a novel role for the palmitoylation 
of membrane proteins. It has recently been proposed that palmi-
toylation of the SNARE protein snf1 prevents recognition by 
the E3 ligases of critical lysines adjacent to the transmembrane 
  domain by affecting protein conformation (Valdez-Taubas and 
  Pelham, 2005). The absence of palmitoylation might also facili-
tate access of E3 ligase to lysines on TEM8/CMG2. However, 
more importantly, palmitoylation serves to spatially segregate 
these membrane proteins away from their Ub ligase, thus con-
trolling their endocytosis.
Figure 10.  Schematic representation of the toxin-induced behavior of TEM8/CMG2 at the cell surface. Cell surface anthrax toxin receptor is palmitoylated 
and localizes to the glycerophospholipidic region of the membrane, where PA83 binds to it. Furin cleavage and heptamerization of PA trigger raft as-
sociation of the toxin–receptor complex (Abrami et al., 2003) in a manner that probably involves a conformational change of the clustered receptors and 
the association with partner proteins, one of which is predicted to be palmitoylated. Within rafts, the receptors become accessible to its E3 Ub ligase, 
possibly Cbl that modiﬁ  es the cytoplasmic tails, thus allowing the interaction with proteins of the endocytic machinery harboring Ub-interacting domains. 
The clathrin-dependent endocytic machinery is thus recruited, and the toxin–receptor complex is internalized.MODIFICATIONS OF ANTHRAX TOXIN RECEPTORS • ABRAMI ET AL. 319
Materials and methods
Proteins and antibodies
Anthrax toxin subunits (Leppla, 1988; Gordon et al., 1995) and aerolysin 
(Buckley, 1990) were puriﬁ  ed as described previously. PA63 was gener-
ated by trypsin cleavage of PA83 (Abrami et al., 2003). Antibodies against 
PA (Liu and Leppla, 2003) and aerolysin (Fivaz et al., 2002) were poly-
clonals developed in our laboratories. Proteins and antibodies were ob-
tained from the following companies: Anti NH2-terminal MEK1 antibodies 
from Upstate Biotechnology; anti–caveolin-1 from Transduction Laborato-
ries; anti-Ub (sc-8017) as well as antibodies and siRNA against human Cbl 
from Santa Cruz Biotechnology, Inc.; anti-HA coupled to beads, labeled, or 
unlabeled with HRP and anti-GFP from Roche; anti-V5 labeled or unlabeled 
with HRP from Invitrogen; HRP secondary antibodies from Pierce Chemical 
Co.; and FITC-conjugated secondary antibodies from Invitrogen.
Cells, plasmids, and transfections
BHK, HeLa, and anthrax toxin receptor–deﬁ  cient CHO (here designated as 
CHO
∆ATR) cells were grown as described previously (Abrami et al., 2003, 
2004; Liu and Leppla, 2003). The human CMG2 (isoform 4) gene tagged 
with a V5 epitope and cloned in the pcDNA3.1/ V5-HIS-TOPO expression 
vector was provided by J. Martignetti (Mount Sinai School of Medicine, 
New York, NY; Dowling et al., 2003). TEM8 isoforms 1 and 2 tagged with 
GFP and cloned in the pHS001-EGFP expression vector was provided by 
J. Young (Salk Institute, San Diego, CA; Rainey et al., 2005). Isoform 1 of 
human TEM8 gene tagged with an HA epitope was in the pIREShyg2 vec-
tor (Liu and Leppla, 2003).
Cysteine to alanine mutant constructs were generated using the 
  QuikChange Site-Directed Mutagenesis Kit (Stratagene) and were trans-
fected into CHO
∆ATR (1 μg cDNA/9.6-cm
2 plate) using Fugene (Roche). 
Stable lines were selected by two rounds of hygromycin resistance. Colo-
nies were isolated by limited dilution. To silence Cbl, HeLa cells were trans-
fected with 200 pmol/9.2-cm2 dish of siRNA using OligofectAMINE 
(Invitrogen) transfection reagent.
Toxin treatment and analysis
Conﬂ  uent cells were incubated in incubation medium (IM; Glasgow mini-
mal essential medium buffered with 10 mM Hepes, pH 7.4) at 4°C for 
1 h with various combinations of proaerolysin, PA, and LF, washed, and 
placed at 37°C in IM for different times. Cells were lysed by incubation for 
30 min at 4°C with radioimmunoprecipitation buffer (1% NP-40, 50 mM 
Tris-HCl, pH 7.4, 0.25% sodium deoxycholate, 150 mm NaCl, 1 mM 
EDTA, and a cocktail of protease inhibitors; Roche). Protein concentrations 
of extracts were determined with bicinchoninic acid (Pierce Chemical Co.). 
To convert surface PA
7mer to an SDS-resistant form, cell extracts were incu-
bated at room temperature for 10 min with 145 mM NaCl and 20 mM 
MES-Tris, pH 4.5. SDS-PAGE was performed using 4–20% gels (NOVEX) 
under nonreducing conditions. Gels were transferred onto nitrocellulose as 
described previously (Abrami et al., 2004).
Drug and enzymatic treatments
To inhibit N-glycosylation, cells were treated with 10 μg/ml tunicamycin 
(Sigma-Aldrich) during the last 16 h of growth. For N-deglycosylation, cell 
extracts were boiled for 5 min with 1% SDS and 1% β-mercaptoethanol, 
diluted ﬁ  vefold in 40 mM phosphate buffer, pH 7.0, containing 10 mM 
EDTA, 1% Triton X-100, 2.5 mM PMSF, and 1% β-mercaptoethanol, and 
were incubated for 16 h at 37°C with 10 U/ml N-glycosidase F. Endo H 
treatment was performed according to the manufacturer’s instructions (New 
England Biolabs, Inc.). Palmitoylation was inhibited by pretreating cells 
with 100 μM 2-bromopalmitate (Sigma-Aldrich) for 1 h at 37°C . Chemical 
removal of S-palmitoylation was performed by treating cell extracts for 1 h 
at room temperature with 1 M hydroxylamine hydrochloride, pH 7.2.
Protein synthesis was blocked by a 30-min treatment with 10 μg/ml 
cycloheximide at 37°C. Endoplasmic reticulum–to-Golgi transport was 
blocked by 20 μg/ml brefeldin A pretreatment for 30 min at 37°C. The 
proteasome inhibitor MG132 (Sigma-Aldrich) was used at 10 μM during 
the 16 h in culture medium. To block lysosomal enzymes, cells were fed for 
16 h with 250 μg/ml leupeptin. To extract cholesterol, cells were treated 
with 10 mM βMCD (Sigma-Aldrich) in IM for 30 min at 37°C, leading to 
a 59.3 ± 3.8% decrease in total cholesterol as measured by thin layer 
chromatography (Abrami and van der Goot, 1999).
Biochemical methods
DRMs were prepared using OptiPrep gradients as described previously 
(Abrami et al., 2003). Six fractions were collected from the top, and the 
  total protein content of each fraction was precipitated with trichloroacetic 
acid (Abrami et al., 2003). For immunoprecipitations of TEM8 or CMG2, 
cells were lysed for 30 min at 4°C in immunoprecipitation buffer (0.5% 
NP-40, 500 mM Tris-HCl, pH 7.4, 20 mM EDTA, 10 mM NaF, 2 mM ben-
zamidine, 1 mM N-ethyl-maleimide, and a cocktail of protease inhibitors), 
centrifuged for 3 min at 2,000 g, and supernatants were incubated for 
2 h at 4°C with either HA-coupled agarose beads (Roche) or protein 
G–  coupled beads (GE Healthcare) with 2 μg monoclonal antibody against 
V5. After washing of the beads, samples were boiled for 5 min under 
  reducing conditions.
Radiolabeling experiments
To follow palmitoylation, TEM8/CMG2-expressing cells were incubated 
for 2 h at 37°C in IM with 200 μCI /ml 
3H-palmitic acid (9,10-
3H(N); 
American Radiolabeled Chemicals, Inc), were washed, and submitted to 
immunoprecipitation. Beads were incubated for 30 min at 60°C in non-
reducing sample buffer before SDS-PAGE. After ﬁ  xation (25% isopropanol, 
65% H2O, and 10% acetic acid), gels were incubated for 30 min in en-
hancer Amplify NAMP100 (GE Healthcare), dried, and exposed to a 
  Hyperﬁ  lm Multipurpose (GE Healthcare).
For metabolic labeling, CHO cells were transiently transfected for 
30 h with TEM8/1-HA cDNAs, washed with methionine/cysteine-free me-
dium, incubated for a 30-min pulse at 37°C with 50 μCi/ml [
35S]methionine/
cysteine (Hartman Analytics), washed, and further incubated for different 
times at 37°C in complete medium with a 10-fold excess of nonradioactive 
methionine and cysteine. Receptors were immunoprecipitated and ana-
lyzed by SDS-PAGE.
Immunoﬂ  uorescence microscopy
CHO cells were ﬁ  xed with 3% formaldehyde, permeabilized with 0.1% 
Triton X-100, and labeled with anti-HA monoclonal antibodies followed by 
ﬂ  uorescein isothiocyanate–conjugated goat anti–mouse IgG. Images were 
acquired using a 100× lens on a microscope (Axiophot; Carl Zeiss Micro-
Imaging, Inc.) equipped with a cooled camera (model Orca; Hamamatsu) 
using the Openlab acquisition software (Improvision).
Online supplemental material
Three supplemental ﬁ  gures are provided. Fig. S1 shows that isoform 2 of 
TEM8, which has a very short cytoplasmic tail (Fig. 1 A), is palmitolyted. 
Fig. S2 shows that this isoform is also ubiquitinated. Finally, Fig. S3 shows 
than when toxin concentrations are adapted so that CCCC TEM8/1– and 
AAAA TEM8/1–expressing cells bind similar amounts of PA, MEK1 cleavage 
is observed in the former cells within an hour but not in the latter cells. 
Online supplemental material is available at http://www.jcb.org/cgi/
content/full/jcb.200507067/DC1.
We thank S. Thurnheer and C. Lucain for generating mutant receptors, D. Hsu 
for making toxins, J. Martignetti and J. Young for providing CMG2 and TEM8 
constructs, and J. Gruenberg, M. Moayeri, and members of the van der Goot 
lab for critical reading of the manuscript.
This work was supported the Swiss National Science Foundation, the 
European Molecular Biology Organization Young Investigator Program, and 
the National Institutes of Health (grant AI053270-01).
Submitted: 14 June 2005
Accepted: 16 December 2005
References
Abrami, L., and F.G. van der Goot. 1999. Plasma membrane microdomains act 
as concentration platforms to facilitate intoxication by aerolysin. J. Cell 
Biol. 147:175–184.
Abrami, L., S. Liu, P. Cosson, S.H. Leppla, and F.G. van der Goot. 2003. Anthrax 
toxin triggers endocytosis of its receptor via a lipid raft-mediated  clathrin-
dependent process. J. Cell Biol. 160:321–328.
Abrami, L., M. Lindsay, R.G. Parton, S.H. Leppla, and F.G. van der Goot. 2004. 
Membrane insertion of anthrax protective antigen and cytoplasmic de-
livery of lethal factor occur at different stages of the endocytic pathway. 
J. Cell Biol. 166:645–651.
Abrami, L., N. Reig, and F.G. van der Goot. 2005. Anthrax toxin: the long and 
winding road that leads to the kill. Trends Microbiol. 13:72–78.
Alvarez, E., N. Girones, and R.J. Davis. 1990. Inhibition of the receptor-
 mediated endocytosis of diferric transferrin is associated with the  covalent 
 modifi  cation of the transferrin receptor with palmitic acid. J. Biol. Chem. 
265:16644–16655.JCB • VOLUME 172 • NUMBER 2 • 2006  320
Bijlmakers, M.J., and M. Marsh. 2003. The on-off story of protein palmitoylation. 
Trends Cell Biol. 13:32–42.
Brown, D.A., and E. London. 1998. Functions of lipid rafts in biological mem-
branes. Annu. Rev. Cell Dev. Biol. 14:111–136.
Buckley, J.T. 1990. Purifi  cation of cloned proaerolysin released by a low 
protease mutant of Aeromonas salmonicida.  Biochem. Cell Biol. 
68:221–224.
Collier, R.J., and J.A. Young. 2003. Anthrax toxin. Annu. Rev. Cell Dev. Biol. 
19:45–70.
Dietzen, D.J., W.R. Hastings, and D.M. Lublin. 1995. Caveolin is palmitoylated 
on multiple cysteine residues. Palmitoylation is not necessary for 
  localization of caveolin to caveolae. J. Biol. Chem. 270:6838–6842.
Dowling, O., A. Difeo, M.C. Ramirez, T. Tukel, G. Narla, L. Bonafe, H. Kayserili, 
M. Yuksel-Apak, A.S. Paller, K. Norton, et al. 2003. Mutations in 
  capillary morphogenesis gene-2 result in the allelic disorders   juvenile 
 hyaline  fi   bromatosis and infantile systemic hyalinosis. Am. J. Hum. 
Genet. 73:957–966.
Drenan, R.M., C.A. Doupnik, M.P. Boyle, L.J. Muglia, J.E. Huettner, M.E. 
Linder, and K.J. Blumer. 2005. Palmitoylation regulates plasma 
  membrane-nuclear shuttling of R7BP, a novel membrane anchor for the 
RGS7 family. J. Cell Biol. 169:623–633.
Fivaz, M., F. Vilbois, S. Thurnheer, C. Pasquali, L. Abrami, P. Bickel, R. Parton, 
and F. van der Goot. 2002. Differential sorting and fate of endocytosed 
GPI-anchored proteins. EMBO J. 21:3989–4000.
Fukata, M., Y. Fukata, H. Adesnik, R.A. Nicoll, and D.S. Bredt. 2004. 
Identifi  cation of PSD-95 palmitoylating enzymes. Neuron. 44:987–996.
Gordon, V.M., K.R. Klimpel, N. Arora, M.A. Henderson, and S.H. Leppla. 
1995. Proteolytic activation of bacterial toxins by eukaryotic cells is 
performed by furin and by additional cellular proteases. Infect. Immun. 
63:82–87.
Haglund, K., and I. Dikic. 2005. Ubiquitylation and cell signaling. EMBO J. 
24:3353–3359.
Haglund, K., I. Ivankovic-Dikic, N. Shimokawa, G.D. Kruh, and I. Dikic. 2004. 
Recruitment of Pyk2 and Cbl to lipid rafts mediates signals important for 
actin reorganization in growing neurites. J. Cell Sci. 117:2557–2568.
Hicke, L., and R. Dunn. 2003. Regulation of membrane protein transport by 
ubiquitin and ubiquitin-binding proteins. Annu. Rev. Cell Dev. Biol. 
19:141–172.
Katzmann, D.J., G. Odorizzi, and S.D. Emr. 2002. Receptor downregulation and 
multivesicular-body sorting. Nat. Rev. Mol. Cell Biol. 3:893–905.
Krantz, B.A., R.A. Melnyk, S. Zhang, S.J. Juris, D.B. Lacy, Z. Wu, A. Finkelstein, 
and R.J. Collier. 2005. A phenylalanine clamp catalyzes   protein 
  translocation through the anthrax toxin pore. Science. 309:777–781.
Lafont, F., and K. Simons. 2001. Raft-partitioning of the ubiquitin ligases Cbl 
and Nedd4 upon IgE-triggered cell signaling. Proc. Natl. Acad. Sci. USA. 
98:3180–3184.
Leppla, S.H. 1988. Production and purifi   cation of anthrax toxin. Methods 
Enzymol. 165:103–116.
Linder, M.E., and R.J. Deschenes. 2004. Model organisms lead the way to 
 protein  palmitoyltransferases.  J. Cell Sci. 117:521–526.
Liu, S., and S.H. Leppla. 2003. Cell surface tumor endothelium marker 8 
  cytoplasmic tail-independent anthrax toxin binding, proteolytic 
  processing, oligomer formation, and internalization. J. Biol. Chem. 
278:5227–5234.
Mack, D., and J. Kruppa. 1988. Fatty acid acylation at the single cysteine residue 
in the cytoplasmic domain of the glycoprotein of vesicular-stomatitis  virus. 
Biochem. J. 256:1021–1027.
Percherancier, Y., T. Planchenault, A. Valenzuela-Fernandez, J.L. Virelizier, F. 
Arenzana-Seisdedos, and F. Bachelerie. 2001. Palmitoylation-dependent 
control of degradation, life span, and membrane expression of the CCR5 
receptor. J. Biol. Chem. 276:31936–31944.
Polo, S., S. Confalonieri, A.E. Salcini, and P.P. Di Fiore. 2003. EH and UIM: 
endocytosis and more. Sci. STKE. doi:10.1126/stke.2132003re17.
Rainey, G.J., D.J. Wigelsworth, P.L. Ryan, H.M. Scobie, R.J. Collier, and J.A. 
Young. 2005. Receptor-specifi  c requirements for anthrax toxin delivery 
into cells. Proc. Natl. Acad. Sci. USA. 102:13278–13283.
Rocks, O., A. Peyker, M. Kahms, P.J. Verveer, C. Koerner, M. Lumbierres, 
J. Kuhlmann, H. Waldmann, A. Wittinghofer, and P.I. Bastiaens. 2005. 
An acylation cycle regulates localization and activity of palmitoylated 
Ras isoforms. Science. 307:1746–1752.
Rothman, J.E. 1994. Mechanisms of intracellular protein transport. Nature. 
372:55–63.
Scheiffele, P., M.G. Roth, and K. Simons. 1997. Interaction of infl  uenza virus 
haemagglutinin with sphingolipid-cholesterol membrane domains via its 
transmembrane domain. EMBO J. 16:5501–5508.
Scobie, H.M., and J.A. Young. 2005. Interactions between anthrax toxin recep-
tors and protective antigen. Curr. Opin. Microbiol. 8:106–112.
Sims, P.J., and T. Wiedmer. 2001. Unraveling the mysteries of phospholipid 
scrambling. Thromb. Haemost. 86:266–275.
Smotrys, J.E., and M.E. Linder. 2004. Palmitoylation of intracellular signalling 
proteins: regulation and function. Annu. Rev. Biochem. 73:559–587.
Valdez-Taubas, J., and H. Pelham. 2005. Swf1-dependent palmitoylation of 
the SNARE Tlg1 prevents its ubiquitination and degradation. EMBO J. 
24:2524–2532.
Webb, Y., L. Hermida-Matsumoto, and M.D. Resh. 2000. Inhibition of protein 
palmitoylation, raft localization, and T cell signaling by 2-bromopalmi-
tate and polyunsaturated fatty acids. J. Biol. Chem. 275:261–270.
Wiedmer, T., J. Zhao, M. Nanjundan, and P.J. Sims. 2003. Palmitoylation of 
phospholipid scramblase 1 controls its distribution between nucleus and 
plasma membrane. Biochemistry. 42:1227–1233.
Wolfe, J.T., B.A. Krantz, G.J. Rainey, J.A. Young, and R.J. Collier. 2005. Whole-
cell voltage clamp measurements of anthrax toxin pore current. J. Biol. 
Chem. 280:39417–39422.
Zhang, W., R.P. Trible, and L.E. Samelson. 1998. LAT palmitoylation: its essen-
tial role in membrane microdomain targeting and tyrosine phosphoryla-
tion during T cell activation. Immunity. 9:239–246.